May 2020
Market Access: Breaking Barriers
_____
Plus: How COVID-19 is changing pharma
featured
Janssen’s Martin Price on having open dialogue with HTAs
_____
Read now
featured
Coronavirus’ effect on drug pricing and reimbursement approvals
_____
Read now